New Issue Published Current Drug Metabolism Vol.17 Issue 10
...
Friday, December 30, 2016
Thursday, December 29, 2016
Most Accessed Article: Drug Interactions with Angiotensin Receptor Blockers: Role of Human Cytochromes P450
Most Accessed Article: Drug Interactions with Angiotensin Receptor Blockers: Role of Human Cytochromes P450
...
Thursday, December 22, 2016
Wednesday, December 14, 2016
Podcast for (Diallyl Sulfide: Potential Use in Novel Therapeutic Interventions in Alcohol, Drugs, and Disease Mediated Cellular Toxicity by Targeting Cytochrome P450 2E1)
Podcast for (Diallyl Sulfide: Potential Use in Novel Therapeutic Interventions in Alcohol, Drugs, and Disease Mediated Cellular Toxicity by Targeting Cytochrome P450 2E1)
...
Thursday, December 8, 2016
Thursday, December 1, 2016
Highlighted Article: Drug-metabolizing Enzymes and Efflux Transporters in Nasal Epithelium: Influence on the Bioavailability of Intranasally Administered Drugs
Highlighted Article: Drug-metabolizing Enzymes and Efflux Transporters in Nasal Epithelium: Influence on the Bioavailability of Intranasally Administered Drugs
...
Thursday, November 24, 2016
Wednesday, November 9, 2016
Call For Paper
Bentham Science Publishers would like to invite you to submit your research paper for publishing in the Journal of
Current Drug Metabolism
...
Wednesday, November 2, 2016
Highlighted Article: The Role of Drug Transporters in the Pharmacokinetics of Antibiotics
The Role of Drug Transporters in the Pharmacokinetics of Antibiotics
Author(s):
Wen Jin Hua, Wei Xiao Hua, Zhou Jian, Peng Hong Wei, Lu Yan Ni, Li Yu Hua, Cao Duan Wen, Zhou Ying and Cao Li Pages 799 - 805 ( 7 )
Abstract:
Background: Various transporters, including efflux transporters and uptake transporters, play an important role in the pharmacokinetics...
Wednesday, October 26, 2016
Most Cited Article: Prodrugs of Quercetin and Resveratrol: A Strategy Under Development
Prodrugs of Quercetin
and Resveratrol: A Strategy Under Development
Author(s):
Lucia Biasutto and Mario ZorattiPages 77-95
(19)
Abstract:
The biochemical activities of plant flavonoids
and stilbenoids point to many health-related applications, hampered however by
a low bioavailability associated with rapid metabolic modification. A possible
approach to overcome this obstacle is the development of prodrugs. In this
review we provide some...
Wednesday, October 19, 2016
Wednesday, October 5, 2016
New Issue ::: Current Drug Metabolism, 17 Issue 8
New Issue ::: Current Drug Metabolism, 17 Issue 8
Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism and disposition. The journal serves as an international forum for the publication of timely reviews and guest edited issues in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical,...
Current Drug Metabolism, 17 Issue 6
Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism and disposition. The journal serves as an international forum for the publication of timely reviews and guest edited issues in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish...
Highlighted Article Flyer for the journal “Current Drug Metabolism” Volume 17, Number 5
courtesy by : https://benthamsciencepublishers.wordpress.com/2016/06/28/highlighted-article-flyer-for-the-journal-current-drug-metabolism-...
Highlighted Article Flyer for the journal “Current Drug Metabolism”
courtesy by : https://benthamsciencepublishers.wordpress.com/2016/06/24/highlighted-article-flyer-for-the-journal-current-drug-metabolis...
Current Drug Metabolism’s newly published issue
Articles from the journal Current Drug Metabolism, 16 Issue 2
Article: Epigenetic Regulation of Cytochrome P450 Enzymes and Clinical Implication
Author(s): Xiaojing Tang and Shuqing Chen
Article: Evidence-Based Choice of P2Y12 Inhibitors in End Stage Renal Disease Patients: A Mini-Review
Author(s): Yassine Bouatou, Caroline Flora Samer, Pierre Fontana, Youssef Daali and Jules Desmeules
Article: Physical...
Wednesday, July 27, 2016
Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process
Author(s):
Kelly E. Caudle, Teri E. Klein, James M. Hoffman, Daniel J. Muller, Michelle Whirl-Carrillo, Li Gong, Ellen M. McDonagh, Katrin Sangkuhl, Caroline F. Thorn, Matthias Schwab, Jose A.G. Agundez, Robert R. Freimuth, Vojtech Huser, Ming Ta Michael Lee, Otito F. Iwuchukwu, Kristine R. Crews, Stuart A. Scott, Mia Wadelius, Jesse J. Swen, Rachel F. Tyndale, C. Michael Stein, Dan Roden, Mary V. Relling, Marc S. Williams and Samuel G. JohnsonPages...
A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics?
Author(s):
Lorena Baietto, Silvia Corcione, Giovanni Pacini, Giovanni Di Perri, Antonio D’Avolio and Francesco Giuseppe De RosaPages 581-598 (18)
Abstract:
Drug bioavailability may vary greatly amongst individuals, affecting both efficacy and toxicity: in humans, genetic variations account for a relevant proportion of such variability. In the last decade the use of pharmacogenetics in clinical practice, as a tool to individualize treatment,...
Preclinical Pharmacokinetics, Pharmacodynamics and Safety of Sucroferric Oxyhydroxide
Author(s):
Mario Cozzolino, Felix Funk, Viatcheslav Rakov, Olivier Phan and Isaac TeitelbaumPages 953-965 (13)
Abstract:
Sucroferric oxyhydroxide (VELPHORO®) is a polynuclear iron-based phosphate binder recently approved for the treatment of hyperphosphataemia in patients with chronic kidney disease (CKD). As a number of the available phosphate binders do not provide the optimal combination of good efficacy, adequate tolerability and low pill...
Role of Drug Metabolism in the Cytotoxicity and Clinical Efficacy of Anthracyclines
Author(s):
Derek W. Edwardson, Rashmi Narendrula, Simon Chewchuk, Kyle Mispel-Beyer, Jonathan P.J. Mapletoft and Amadeo M. ParissentiPages 412-426 (15)
Abstract:
Many clinical studies involving anti-tumor agents neglect to consider how these agents are metabolized within the host and whether the creation of specific metabolites alters drug therapeutic properties or toxic side effects. However, this is not the case for the anthracycline class...
Digestive Enzyme Supplementation in Gastrointestinal Diseases
Author(s):
Gianluca Ianiro, Silvia Pecere, Valentina Giorgio, Antonio Gasbarrini and Giovanni CammarotaPages 187-193 (7)
Abstract:
Background: Digestive enzymes are able to break down proteins and carbohydrates and lipids, and their supplementation may play a role in the management of digestive disorders, from lactose intolerance to cystic fibrosis. To date, several formulations of digestive enzymes are available on the market, being different...
